Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.5053-0.0225 (-4.26%)
At close: 4:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/27/2021
Current
Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.33
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.1200
52 Week Low 30.4600
50-Day Moving Average 30.5632
200-Day Moving Average 30.9380

Share Statistics

Avg Vol (3 month) 314.72M
Avg Vol (10 day) 324.6M
Shares Outstanding 5330.54M
Implied Shares Outstanding 6N/A
Float 8357.29M
% Held by Insiders 10.07%
% Held by Institutions 121.55%
Shares Short (Sep 14, 2021) 49.93M
Short Ratio (Sep 14, 2021) 40.84
Short % of Float (Sep 14, 2021) 42.78%
Short % of Shares Outstanding (Sep 14, 2021) 42.78%
Shares Short (prior month Aug 12, 2021) 413.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 31, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Oct 31, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-37.03%
Return on Equity (ttm)-62.56%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -73.29M
Net Income Avi to Common (ttm)-73.22M
Diluted EPS (ttm)-0.3960
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)165.72M
Total Cash Per Share (mrq)0.46
Total Debt (mrq)1.05M
Total Debt/Equity (mrq)0.58
Current Ratio (mrq)21.94
Book Value Per Share (mrq)0.55

Cash Flow Statement

Operating Cash Flow (ttm)-69.36M
Levered Free Cash Flow (ttm)-56.77M
Advertisement
Advertisement